Reuters logo
BRIEF-FDA grants orphan drug designation to Kadmon’s KD025
October 6, 2017 / 1:22 PM / 12 days ago

BRIEF-FDA grants orphan drug designation to Kadmon’s KD025

Oct 6 (Reuters) - Kadmon Holdings Inc

* FDA grants orphan drug designation to Kadmon’s KD025 for the treatment of CGVHD

* Kadmon Holdings Inc - ‍Anticipate presenting additional data from KD025 study toward end of this year​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below